Back to Markets
DBDbv Technologies SA

Dbv Technologies SA

DBVTNYSE EURONEXT - EURONEXT PARIS
Health CareBiotechnology

$19.10

+0.1100 (+0.58%)

As of 05/29/26 EDT · USD

Compare
Low: $7.53Current: $19.10High: $26.19

Key Statistics

Open

$18.75

Day High

$19.81

Day Low

$18.64

Prev. Close

$18.99

VolumeShares traded today.

265.03K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$1.13B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-3.60

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$26.19

52W LowLowest price over the past 52 weeks.

$7.53

50D MAAverage closing price over the last 50 trading days.

$19.99

200D MAAverage closing price over the last 200 trading days.

$17.10

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+2.9%

1M

-5.9%

6M

+47.4%

YTD

+0.3%

1Y

+146.8%

About

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

www.dbv-technologies.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNYSE EURONEXT - EURONEXT PARIS
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade DBVT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.